By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences said in a US Securities and Exchange Commission filing Friday that it has received another notice from Nasdaq warning the company that its shares will be delisted as of the opening of business on Oct. 21, unless an appeal is filed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.